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The mammalian mitochondrial inner membrane protein
Oxa1L is involved in the insertion of a number ofmitochondrial
translation products into the inner membrane. During this
process, the C-terminal tail of Oxa1L (Oxa1L-CTT) bindsmito-
chondrial ribosomes and is believed to coordinate the synthesis
and membrane insertion of the nascent chains into the mem-
brane. The C-terminal tail of Oxa1L does not contain any Cys
residues. Four variants of this protein with a specifically placed
Cys residue at position 4, 39, 67, or 94 of Oxa1L-CTT have been
prepared. These Cys residues have been derivatized with a fluo-
rescent probe, tetramethylrhodamine-5-maleimide, for bio-
physical studies. Oxa1L-CTT forms oligomers cooperatively
with a binding constant in the submicromolar range. Fluores-
cence anisotropy and fluorescence lifetime measurements indi-
cate that contacts near a long helix close to position 39 of
Oxa1L-CTT occur during oligomer formation. Fluorescence
correlation spectroscopy measurements demonstrate that all of
the Oxa1L-CTT derivatives bind to mammalian mitochondrial
ribosomes. Steady-state fluorescence quenching and fluores-
cence lifetime data indicate that there are extensive contacts
between Oxa1L-CTT and the ribosome-encompassing regions
around positions 39, 67, and 94. The results of this study suggest
that Oxa1L-CTT undergoes conformational changes and
induced oligomer formation when it binds to the ribosome.
Mammalian mitochondria synthesize 13 hydrophobic pro-
teins that are components of the respiratory chain complexes in
the inner membrane. Protein synthesis in this organelle is per-
formed by specialized ribosomes, which are quite distinct from
the ribosomes of other translational systems. In particular, they
are quite rich in protein and have truncated rRNAs (1). Because
of the presence of regions of high hydrophobicity, mitochon-
drially synthesized proteins are thought to be integrated into
the membrane during or immediately following their synthesis
on mitochondrial ribosomes.
Mitochondrial ribosomes are associated with the inner
membrane (2, 3), and several proteins have been implicated in
the binding of these ribosomes to the membrane. The best
characterized of these are members of the Oxa1 family of pro-
teins. Oxa1 is located in the inner membrane, where it acts as a
component of themachinery thatmediates the insertion of cer-
tain hydrophobic proteins into themembrane. It belongs to the
YidC and Alb3 family of proteins found throughout pro-
karyotes and eukaryotes (4, 5). The human form is designated
Oxa1L. Oxa1L consists of an N-terminal section located in the
mitochondrial intermembrane space, five transmembrane
helices, and a C-terminal tail of 100 amino acids exposed in
the mitochondrial matrix (6).
The C-terminal tail of the yeast homolog of Oxa1L (Oxa1p)
has been shown to bind mitochondrial ribosomes (6). Deletion
of this region of Oxa1p severely diminishes the efficiency of
membrane insertion of subunit II of cytochrome oxidase, indi-
cating that the C-terminal tail of yeast Oxa1p plays an active
role in the insertion of mitochondrial translation products into
the lipid bilayer (6). Cryo-EM studies of yeast Oxa1p bound to
bacterial ribosomes indicate that it interacts near the exit tun-
nel located on the back of the large ribosomal subunit (7).
Previous studies of the C-terminal tail of human Oxa1L
(Oxa1L-CTT)2 suggested that, in solution, the C-terminal tail
exists as an equilibrium of the monomer, dimer, and tetramer
forms (8). Circular dichroism studies indicated that it contains
20% -helical content. Despite predictions based on yeast
Oxa1p, human Oxa1L-CTT does not form a coiled-coil struc-
ture. Two copies of Oxa1L-CTTbind to ribosomeswith a bind-
ing constant in the range of 0.3–0.8 M. Cross-linking studies
suggested that Oxa1L-CTT contacts three proteins that have
bacterial homologs (MRPL13, MRPL20, and MRPL28) and
three proteins that are unique to mitochondrial ribosomes
(MRPL48,MRPL49, andMRPL51). These proteins are believed
to be located on the solvent side of the large ribosomal subunit
(8). Despite this recent work, our understanding of the struc-
ture of human Oxa1L-CTT and its interaction with the mam-
malian mitochondrial ribosomes is quite limited. In this study,
we have investigated the regions of Oxa1L-CTT that interact
during formation of the oligomer and examined which regions
of Oxa1L-CTT interact with the ribosome using static and
dynamic fluorescence spectroscopy.
EXPERIMENTAL PROCEDURES
Materials—High-purity grade chemicals were purchased
from Sigma or Fisher. Tetramethylrhodamine-5-maleimide
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was obtained from Invitrogen. Sephadex G-15 was pur-
chased from Sigma. Bovine mitochondria and mitochondrial
ribosomes (55 S) and ribosomal subunits (28 S and 39 S) were
prepared as described previously (9).
Preparation of Mutant Derivatives of Oxa1L-CTT—The
cDNA clone of mature human Oxa1L was obtained from
American Type Culture Collection (ATCC 10961183, IMAGE
40017377). The region encompassing the C-terminal tail was
cloned, expressed, and purified as described previously (8).
Four mutant derivatives were prepared in which specific resi-
dues were converted to Cys (A4C, A39C, T67C, and S94C)
(shown in Fig. 1, upper). These derivatives were prepared using
the QuikChange site-directed mutagenesis protocol (Strat-
agene) and forward primersCGGATTCCATGTGTACGCAC-
TGTACTTAAAATC (for position 4), GGCTGGAAAAATT-
GTGAAATGACG (for position 39), GGTCCTCGACAGTG-
TTTTACCCAC (for position 67), and AGCAAACCAAAGT-
GTAAGTATCCC (for position 94). The reverse primers used
were the inverse complements of the forward primers in each
case. All mutations carrying Oxa1L-CTT were transformed
intoEscherichia coliDH5, and the nucleotide sequences of the
inserted DNAs were confirmed. The variants are designated
Oxa4-CTT, Oxa39-CTT, Oxa67-CTT, and Oxa94-CTT, indi-
cating the position of the Cys residue. The mutant plasmids
were subsequently transformed intoE. coliBL21(DE3) RIL cells
(Stratagene) for expression. Cells were grown to an A600 of 0.6
in LB medium containing 100 g/ml ampicillin and 34 g/ml
chloramphenicol and induced by the addition of 50 M isopro-
pyl 1-thio--D-galactopyranoside for 6 h at 37 °C. After induc-
tion, cells were lysed, and Oxa1L-CTT was purified using nick-
el-nitrilotriacetic acid resin, followed by HPLC purification on
a TSKgel SP-5PW cation exchange column as described previ-
ously (8) except that buffers contained 1mM tris(2-carboxyeth-
yl)phosphine hydrochloride (TCEP) as the reducing agent
unless indicated otherwise. Proteins were purified with and
without TCEP, keeping all other conditions the same. The
mutant derivatives were tested for structural integrity by com-
paring the -helical content obtained using circular dichroism
with that ofwild-typeOxa1L-CTT.The secondary structures of
the Oxa1L-CTT variants did not change upon mutation at any
of these positions.
Detection of Dimers by S–S Bond Formation—Oxa1L-CTT
variants prepared in the absence of TCEP (5 g, 10 l) were
kept under slow passing O2 gas for 30min and then held at 4 °C
overnight in buffer containing 20 mM HEPES-KOH (pH 7.6)
and 50 mM KCl in the presence and absence of 10 mM MgCl2.
An equal volume of 2 SDS loading dye without -mercapto-
ethanol was added to the reaction mixtures. Samples were run
on a 15% SDS-polyacrylamide gel. The gel was stained with
Coomassie Blue, and the monomer and dimer bands were
quantified using UN-SCAN-IT gel software.
Fluorescence Tagging of the Oxa1L-CTT Derivatives with
Rhodamine—Each HPLC-purified Oxa1L-CTT variant (78 M
in 500 l, 1 mg/ml) was labeled with rhodamine-5-maleimide
basically as described by the manufacturer, producing Oxa4-
Rh, Oxa39-Rh, Oxa67-Rh, and Oxa94-Rh. The concentrated
fluorescent probe (33mMdissolved inMe2SO)was added to the
protein solution in buffer containing 20 mM HEPES-KOH (pH
7.6), 50 mM KCl, and 1mMTCEP at a molar ratio of 5:1 (probe/
protein). The mixture (500-l final volume) was incubated for
1 h at room temperature with gentle shaking in the dark. The
reactions were quenched by the addition of excess -mercap-
toethanol (100 mM). Tagged proteins were separated from free
dye by chromatography on a Sephadex G-15 column (0.7  20
cm) equilibrated in buffer containing 20 mMHEPES-KOH (pH
7.6), 50 mM KCl, 10 mM MgCl2, 10% glycerol, and 1 mM TCEP.
The protein concentration was calculated using the following
formula: protein concentration (M)  (A280  AmaxCF)/,
whereAmax is the absorbance of rhodamine-5-maleimide at the
wavelength maximum (550 nm), CF is the correction factor
(CF  A280(free dye)/A550(free dye)), and  is the molar extinction
coefficient of Oxa1L-CTT based on the amino acid composi-
tion (12,700 M1 cm1). The CF value is equal to 0.34 (Thermo
Scientific). The degree of labeling was calculated using the fol-
lowing formula: % labelAmax of the labeled protein/protein
concentration, where  is the molar extinction coefficient of
the fluorescent dye (65,000 M1 cm1). The tagging efficiency
was 70–100%.
Measurement of Rhodamine Steady-state Fluorescence Inten-
sity and Anisotropy to Detect the Oligomer-forming Segments of
Oxa1L-CTT and Binding to Ribosomes—The rhodamine fluo-
rescence anisotropy of Oxa4-Rh, Oxa39-Rh, Oxa67-Rh, and
Oxa94-Rhwas examined on an SLM48000 spectrofluorometer
(SLM Aminco, Urbana, IL) using an excitation wavelength of
545 nm and an emission wavelength of 573 nm. The rhoda-
mine-tagged protein (100 nM) was in 20 mM HEPES-KOH (pH
7.6), 50 mM KCl, 5 mM MgCl2, and 1 mM TCEP. Data were
collected in L-format using 0.4-cm path length quartz cuvettes
with 5-nm excitation and 5-nm emission slits at 25 °C in the
absence and presence of the indicated concentrations of wild-
type Oxa1L-CTT. Control measurements using the corre-
sponding buffer containing wild-type Oxa1L-CTT were
recorded and subtracted from the sample readings. The fluo-
rescence anisotropy was calculated using the following equa-
tion: r  (Ivv  GIvh)/(Ivv  2GIvh), where Ivv is the polarized
emission intensity with vertical excitation and vertical emission
polarizers, Ivh is the polarized emission intensity with vertical
excitation and horizontal emission polarizers, and G is the
instrumental correction factor (G-factor  Ihv/Ihh, where Ihh is
the polarized emission intensity with horizontal excitation and
horizontal emission polarizers). For Oxa-Rh binding to ribo-
somes, rhodamine fluorescence intensitywas recordedwith the
addition of ribosomes, keeping the same conditions as
described above. Background intensity (ribosome alone in
buffer) wasmonitored and subtracted from the sample reading.
Measurement of Protein Dynamics Using Fluorescence Corre-
lation Spectroscopy (FCS) and Time-correlated Single-photon
Counting (TCSPC)—FCS and TCSPCmeasurements were per-
formed using a home-built, two-photon optical microscope
(10, 11). This instrument uses ultrashort pulses generated by a
Coherent Chameleon Ultra II laser (140-fs pulse duration,
80-MHz repetition rate), which is tuned to 825 nm for optimal
excitation of rhodamine. The laser output is attenuated by a
low-bandwidth electro-optic modulator and is then directed
through a second higher bandwidth electro-optic modulator
that permits individual pulse selection (both modulator sys-
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tems from Conoptics Inc., Danbury, CT). Residual visible light
is removed by a long-wave pass filter (HQ690LP, Chroma,
Rockingham, VT) before the laser beam enters an Olympus
IX-81 inverted microscope through laser port B. It is focused
into the sample by a 60 1.2-numerical aperture water immer-
sion objective; the back aperture of this lens is slightly overfilled
to create a diffraction-limited focal spot. Epifluorescence col-
lected by the objective is separated from the excitation beam by
a long-pass dichroic filter (670DCXXRU, Chroma). Full sup-
pression of the IR light and of the emission from aminor impu-
rity in the ribosomal samples is accomplished with a short-pass
dichroic filter (FF01-680/SP, Semrock, Rochester, NY) and a
band pass filter (HQ630/100m-2P, Chroma). The optically fil-
tered fluorescence is detected by a GaAsP photomultiplier tube
(H7422P-40mod, Hamamatsu), the output of which is sent to a
custom-designed preamplifier that has both a high-bandwidth
amplified output channel and a discriminated digital output
channel.
FCS measurements are accomplished by sending the digital
preamplifier output to an external correlator (Flex03LQ-12,
Correlator.com). These experiments were performed at the full
80-MHz pulse repetition rate, and the excitation power at the
sample was typically 5–6milliwatts. Experiments performed at
lower powers resulted in identical correlation curves. The
correlation curves were fit to the models described under
supplemental “Methods” using a least-squares algorithm in
MATLAB.
For TCSPC measurements, the pulse repetition rate was
reduced to 5MHz by the high-bandwidthmodulator, and sam-
ples were excitedwith pulse energies of3 nJ. A polarizer set at
themagic angle was inserted into the fluorescence path to elim-
inate signal contributions from molecular reorientation. Addi-
tionally, a coverslip placed in the laser beam path was used to
direct a small fraction of the excitation light to a fast photodiode
for use as a timing reference. To record TCSPC curves, the
photodiode output and the high-bandwidth output of the pho-
tomultiplier tube preamplifier were sent to a single-photon
counting module (SPC-130, Becker & Hickl). The instrument
response function (full width at half-maximum  260 ps) was
measured by collecting the second harmonic signal generated
by potassium phosphate crystals placed at the sample position.
Fluorescence decay curves were fit using a least-squares algo-
rithm in MATLAB by convolving a single-exponential or biex-
ponential decay with the instrument response function.
RESULTS
Oxa1L-CTT is a matrix-exposed domain that binds to mito-
chondrial ribosomes and plays a role in the insertion of mito-
chondrially synthesized proteins into the inner membrane.
There is no direct structural information on this protein. How-
ever, a three-dimensional model has been developed using
Rosetta (8). In this model (Fig. 1), Oxa1L-CTT contains a long
-helical segment along with several shorter helical regions
(Fig. 1). Four mutants were prepared to place Cys residues at
specific positions of Oxa1L-CTT. The first mutation converted
Ala4 to Cys (the numbers refer to amino acid residues in the
C-terminal tail, which encompasses residues 334–436 of the
full-length protein) and was expected to be positioned close to
the membrane. The second mutation converted Ala39 to Cys
and was located at the base of the long helical segment. The
third mutation (Thr67 to Cys) was in a loop region predicted to
lie close to the long helix. Finally, the fourth mutation (Ser94 to
Cys) was found close to the C terminus (Fig. 1). CD results
indicated that the secondary structures of all Oxa1L-CTT
derivatives were the same as that of wild-type Oxa1L-CTT
under several buffer conditions, including the presence and
absence of Mg2, indicating that the secondary structures of
the variants are the same as that of the wild-type protein.
Oxa1L-CTT forms oligomers, predominantly dimers, in
solution (8). To assess the regions of Oxa1L-CTT that might be
in close contact in the dimer, S–S bond formation in the unla-
beled proteins was forced by passing O2 through a solution of
each derivative, followed by SDS-PAGE analysis to separate
monomers and dimers. The amount of dimer formedwith each
derivative was quantified by measuring the band intensity. In
the presence ofMgCl2, almost 100% of Oxa39 was converted to
a dimer, whereas Oxa4, Oxa67, and Oxa95 formed 25, 60, and
65% dimers, respectively (Fig. 2). The easy formation of a disul-
fide bond at position 39 ofOxa1L-CTT suggests that this region
of the protein is in contact in the dimer. Other regions have a
lower tendency to form dimers, suggesting less direct contact
between them in the dimer. In the absence of MgCl2, signifi-
cantly different results were observed, with Oxa94 forming the
most dimers and a decrease in dimer formation at position 39.
There was a limited change at positions 4 and 67 in the absence
of Mg2. The different patterns obtained in the presence and
absence of Mg2 indicate that this cation induces local confor-
mational changes in Oxa1L-CTT. The effect of Mg2 could
arise from the binding of this cation to acidic residues in
Oxa1L-CTT, such as the RERE sequence in the long helical
FIGURE 1. Upper, the primary sequence of the Oxa1L-CTT, with different colors
indicating the positions where Cys was used to replace the given amino acids.
The expressed protein has a methionine at the start of the sequence and
LE-His6 at the C terminus from the vector (not shown in the sequence). Lower,
computer-generated three-dimensional structure of Oxa1L-CTT developed
using Rosetta (26) and displayed using PyMOL. The Cys residues incorporated
at the indicated positions are shown space-filled and in different colors.
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segment with position 39. Another possibility is the interaction
of Mg2 with the Glu residues at positions 26 and 30, perhaps
stabilizing the short helical segment in which these residues are
present.
Mitochondrial protein synthesis requires Mg2, suggesting
that results obtained with Mg2 are the more physiologically
relevant. The concentration of monovalent salt (50–300 mM
KCl) and the pH (5.5–8.5) had no effect on S–S bond formation
(data not shown).
Identification of the Interacting Regions in the Oxa1L-CTT
Oligomer during Formation Using Fluorescence Anisotropy
Measurements—The disulfide cross-linking results suggested
that the residues near position 39 are in contact in the dimer.
However, random S–S bonds can form even from monomeric
proteins due to random collisions. To obtain further insights
into interactions that could occur in the dimer, theCys residues
in each mutant protein were derivatized with rhodamine, lead-
ing to Oxa4-Rh, Oxa39-Rh, Oxa67-Rh, and Oxa94-Rh, respec-
tively. Each of these proteins could be fluorescently tagged with
a stoichiometry of 0.7–1.0. The labeled mutants were then
tested for oligomer formation using fluorescence anisotropy.
Rhodamine-labeled proteins have previously been used to
study protein-protein, protein-ribosome, and protein-mem-
brane interactions (12–15).
The ability of Oxa1L-CTT to form homo-oligomers was
measured bymonitoring the change in fluorescence anisotropy
of the Oxa-Rh derivatives by adding increasing concentrations
of unlabeled (wild-type) Oxa1L-CTT (Fig. 3). There was essen-
tially no change in anisotropy for theOxa1L-CTTderivatives at
positions 4, 67, and 94. The anisotropy of Oxa39-Rh showed
little change with the addition of wild-type Oxa1L-CTT up to
10Mbut then increasedwith increasing concentrations until a
maximum value was reached. This result clearly indicates that
the segmental motion of rhodamine at position 39 is hindered
(restricted rotation) in the presence of wild-type Oxa1-CTT
due to oligomerization. The data for Oxa39-Rh were fit to a
sigmoidal curve, indicating that Oxa1L-CTT forms homo-olig-
omers (dimers and tetramers) with cooperative binding. Previ-
ous work has indicated that Oxa1L-CTT exists as monomers,
dimers, and tetramers in solution (8). The EC50 value (midpoint
of the curve) and slope do not have much physical meaning in
the context of our monomer-dimer-tetramer association but
support an adequate description of the transition from mono-
mer to oligomer as a function of total protein concentration.
Salt (KCl) and rhodamine-tagged protein concentration data
also suggest that the region around position 39 is involved
mainly in oligomer formation (supplemental Fig. S1, A and B).
In addition to the anisotropy change inOxa39-Rh, the intensity
of the fluorescence also decreased (by 35%) with increasing
salt and elevated protein concentrations (data not shown). Nei-
ther the intensity not the anisotropy of the other three deriva-
tives changed under these conditions. This result indicates that
with increasing Oxa1L concentrations and salt, rhodamine
probes at position 39 come close together and self-quench,
leading to a decrease in intensity and anisotropy (16, 17).
Microenvironment of Oxa1L-CTT Variants in Solution—We
further investigated the local environment of rhodamine in
each labeled position ofOxa1L-CTTbymeasuring the time-de-
pendent fluorescence of each derivative under a variety of con-
ditions. Fig. 4a compares the fluorescence decay of free rhoda-
mine with that of Oxa1L-CTT labeled with rhodamine at
positions 4 and 94 (each at 100 nM). The fluorescence lifetime
clearly changed when rhodamine was attached to the protein,
and it depended on the attachment position. Previous studies
(18, 19) have found that the fluorescence lifetime of rhodamine
B, which is structurally similar to the tetramethylrhodamine
derivative used to label Oxa1L-CTT, varies greatly according to
the solvent in which it is dissolved. Its lifetime is roughly corre-
lated with the solvent polarity: 1.7 ns in water, 2.5 ns in metha-
nol, 2.9 ns in ethanol, and 3.3 ns in isopropyl alcohol. On the
basis of this information, we assume that the fluorescence life-
time of rhodamine is a good indicator of its local environment.
When the samples in Fig. 4a were fit to a single-exponential
FIGURE 2. Efficiency of disulfide bond formation of Oxa1L-CTT mutants.
Samples were treated as described under “Experimental Procedures” and
analyzed by SDS-PAGE. Bands were quantified using UN-SCAN-IT gel soft-
ware and are plotted as the percent S–S with respect to different mutants. FIGURE 3. Detection of regions of Oxa1L-CTT in close proximity using
steady-state fluorescence anisotropy measurements. Proteins tagged
with rhodamine were examined using fluorescence anisotropy in the
absence and presence of wild-type Oxa1L-CTT. The data are plotted as the
change in anisotropy (AOxa-Rhwild-type Oxa  AOxa-Rh) as a function of wild-
type Oxa1L-CTT concentration. The rhodamine-labeled protein concen-
tration was 100 nM, and the experimental details are described under
“Experimental Procedures.”
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decay, the fluorescence lifetimes were 1.61, 2.38, and 3.18 ns for
free rhodamine, Oxa4-Rh, and Oxa94-Rh, respectively (Table
1). It is not surprising that the local environment of rhodamine
attached to the protein is less polar than in solution, but the
lifetime data further indicate that rhodamine attached in posi-
tion 94 is in a significantly less polar environment than rhoda-
mine in position 4. The fluorescence lifetimes of the other
Oxa1L-CTT derivatives at 100 nM indicate that the environ-
ment of rhodamine in position 39 is similar to that in position 4,
whereas rhodamine in position 67 experiences an intermediate
polarity. The steady-state anisotropy values were consistent
with these results (0.1 for Oxa4-Rh and Oxa39-Rh, 0.147 for
Oxa67-Rh, and 0.156 for Oxa94-Rh).
Interaction of Oxa1L-CTTwith Ribosomes and Identification
of Interacting Regions—It has been shown previously that
Oxa1L-CTT binds to ribosomes with a Kd of 0.3–0.8 M and
that two Oxa1L-CTTs bind to one ribosome (8). We used two-
photon excited FCS to test the ability of the Cys mutants of
Oxa1L-CTT to bind ribosomes. FCSmeasures time-dependent
fluctuations in the amount of fluorescence arising from a spa-
tially limited observation volumewithin a sample (10, 11). Such
fluctuations are most typically due to fluorophore diffusion
through the observation volume; in this case, the characteristic
time scale over which the fluorescence autocorrelation func-
tion decays (referred to as the correlation time) is inversely
related to the rate of molecular diffusion. Thus, FCS can detect
the association ofmolecules in solution by observing changes in
their diffusion and is particularly useful for studying the asso-
ciation of large species with smaller fluorescent molecules.
Normalized fluorescence correlation functions of rhoda-
mine, rhodamine-labeled Oxa1L-CTT derivatives alone, and
rhodamine-labeled Oxa1L-CTT derivatives in the presence of
ribosomes are plotted in Fig. 5. The correlation time of each of
the rhodamine-labeled Oxa1L-CTT derivatives was longer
than that of free rhodamine due to the increased molecular
size. The correlation functions of rhodamine and all of the free
protein derivatives could be fit by a model for a single diffusing
species (see supplemental “Methods”).
The curves for each protein in the presence of ribosomes
contain a pronounced shoulder at longer lag times. These data
can be fit using a two-component model in which the correla-
tion time of the more quickly diffusing species matches that of
the free Oxa1L-CTT derivative; we attribute the slowly diffus-
ing species to the bound protein-ribosome complexes. All of
the rhodamine-labeled Oxa1L-CTT derivatives bound ribo-
somes similarly.We performed control experiments to demon-
strate that the background fluorescence in the ribosomal sam-
ples was insignificant and that free rhodamine did not interact
with the ribosome or wild-type Oxa1L-CTT.
The FCS results clearly indicate that the fluorescently tagged
Oxa1L-CTT derivatives are all active in binding mitochondrial
ribosomes. However, these data cannot provide information on
which part of the protein contacts the ribosome or on how the
twoOxa1L-CTT oligomers are organized upon ribosome bind-
ing. To obtain a more detailed picture of these interactions, we
measured the fluorescence intensity and fluorescence lifetime
of the rhodamine-labeled Oxa1L-CTT derivatives in the
absence and presence of ribosomes.
The self-quenching behavior of rhodamine was used to
examine regions of the two Oxa1L-CTT monomers that are in
FIGURE 4. Time-dependent fluorescence of rhodamine-labeled Oxa1L-
CTT mutants as an indication of the local environment in various regions
of the protein. Samples were excited using two-photon absorption, and
emission was detected at the magic angle to remove anisotropic contribu-
tions. a, normalized (norm) time-dependent fluorescence decays of free rho-
damine B, Oxa4-Rh, and Oxa94-Rh. The other derivatives were omitted for
clarity. b, comparison of Oxa94-Rh in the absence and presence of ribosomes.
The protein concentration was 100 nM, and the ribosome concentration was
200 nM.
TABLE 1
Time-dependent fluorescence optimized fitting parameters
Each time-dependent fluorescence decay curve was fit to both a one-component (aexp(t/)) model and a two-component (a1exp(t/1)  a2exp(t/2)) model. The
models were compared by calculating the 2CFI as the fractional decrease in the residual sum of squares for the biexponential fit expressed as a percentage, as defined under
“Results.” The two-component fit was used for samples that exhibited 2CFI values larger than 35%, but otherwise a one-component fit was considered adequate. Optimized
fitting parameters of the most appropriate model for each sample are listed; values are the mean S.D. for three to five datasets. The amplitude of each fitting function was
normalized; only the value of a1 is listed for the two-component fit because a1  a2  1.
2CFI value One-component fit ()
Two-Component fit
a1 1 2
% ns ns ns
Rhodamine (100 nM) 3 1.61  0.06
Rhodamine (500 nM) 29 1.61  0.04
Oxa4-Rh (100 nM) 1 2.38  0.16
Oxa4-Rh (500 nM) 18 2.37  0.03
Oxa4-Rh  ribosome 28 2.50  0.22
Oxa39-Rh (100 nM) 34 2.35  0.14
Oxa39-Rh (500 nM) 83 0.25  0.09 0.51  0.10 2.46  0.20
Oxa39-Rh  ribosome 189 0.44  0.03 0.82  0.16 2.89  0.20
Oxa67-Rh (100 nM) 17 2.65  0.10
Oxa67-Rh (500 nM) 29 2.64  0.36
Oxa67-Rh  ribosome 125 0.40  0.05 1.00  0.25 3.06  0.20
Oxa94-Rh (100 nM) 8 3.18  0.13
Oxa94-Rh (500 nM) 31 2.97  0.38
Oxa94-Rh  ribosome 158 0.50  0.07 0.76  0.25 3.42  0.22
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close proximity when bound to the ribosome. As indicated in
Fig. 6, very little decrease in fluorescence intensity (self-
quenching) was observed with Oxa4-Rh, indicating that this
region of the protein is not in close proximity when Oxa1L-
CTT is bound to the ribosome. However, changes in fluores-
cence intensity were observed with Oxa1L-CTT labeled at
position 39, 67, or 94. This observation indicates that the rho-
damine probes at these positions have come closer together. Of
these three positions, only position 39 appeared to be close in
Oxa1L-CTT when the dimer (oligomer) was formed in solu-
tion. This close proximity is reflected in the interaction of the
two copies of Oxa1L-CTT bound to the ribosome as observed
previously (8). Furthermore, these data indicate that the
regions of the protein near positions 67 and 94, which were not
close together in the dimer in solution, underwent conforma-
tional changes upon the binding of Oxa1L-CTT to the ribo-
some, bringing them into close proximity. The data were fit
using a simple binding model; the apparent Kd is 25 nM. The
Kd in this study is lower than the value obtainedwith isothermal
titration calorimetry and surface plasmon resonance used in a
previous study (8). The difference in the Kd could be due to
differences in the percentage of active ribosomes in various
preparations or to inactivation of a portion of the ribosomes in
some of the previous measurements.
With the exception of Oxa4-Rh, in the presence of ribo-
somes, the time-dependent fluorescence of the rhodamine-
labeled Oxa1L-CTT derivatives did not adhere to a single-ex-
ponential decay (Table 1). This behavior is exemplified by
comparing Oxa94-Rh in the absence and presence of ribosomes
(Fig. 4b). It is clear that a biexponential decaymodel is required
to fit the latter data; however, the choice between a single-ex-
ponential and a biexponentialmodel is not as apparent for some
samples (Fig. 7). To obtain a quantitative comparison of the two
models, we used the residual sum of squares that resulted from
a single-exponential and a biexponential fit of each decay curve.
FIGURE 5. Binding of rhodamine-labeled Oxa1L-CTT mutants to ribo-
somes using two-photon excited FCS. Shown are normalized autocorrela-
tion curves of rhodamine (blue), Oxa1L-CTT derivatives alone (green), and
Oxa1L-CTT derivatives in the presence of ribosomes (red). FCS curves for rho-
damine and the protein-only samples were fit to a one-component model;
samples containing protein and ribosomes were fit to a two-component
model. The protein concentration was 100 nM, and the ribosome concentra-
tion was 200 nM. Supplemental “Methods” contains more information about
the models, best fit curves, and optimized fitting parameters.
FIGURE 6. Interaction of Oxa1L-CTT derivatives with ribosomes using
rhodamine fluorescence intensity quenching. The fluorescence (Fluo.)
intensity of rhodamine-labeled Oxa1L-CTT mutants (100 nM) was measured in
buffer and in the presence of different concentrations of ribosomes, and the
normalized intensity is plotted as a function of the ribosome concentration.
FIGURE 7. Data-fitting strategy for time-dependent fluorescence decays
of rhodamine-labeled Oxa1L-CTT mutants. Each dataset was separately fit
to a one-component (single-exponential) model and to a two-component
(biexponential) model. The residual sum of squares for the two models was
compared to determine the most appropriate model for each sample, as
described under “Results” and in Table 1. Upper left, Oxa4-Rh (500 nM) fit by a
single-exponential model. Upper right, Oxa4-Rh (100 nM)  ribosome (200 nM)
fit by a single-exponential model. Lower left, Oxa94-Rh (500 nM) fit by a single-
exponential model and a biexponential model. Both fits track the data rea-
sonably well, but the single model was deemed adequate according to the
criteria outlined under “Results.” Lower right, Oxa94-Rh (100 nM)  ribosome
(200 nM) fit to a single-exponential and a biexponential model. The biexpo-
nential model is required to adequately fit the data.
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We defined the two-component fit improvement (2CFI) as
the fractional decrease in the residual sum of squares (RSS) for
the biexponential fit expressed as a percentage: 2CFI 
100((RSS2-component  RSS1-component)/RSS2-component). Be-
cause of experimental noise, the biexponentialmodel improved
the fit for nearly all experimentally measured decay curves
(2CFI  0), so we further required a threshold value to use in
assigning the most appropriate model for each decay curve.
Because free rhodamine is expected to exhibit single-exponen-
tial fluorescence decay kinetics at submicromolar concentra-
tions, we set the threshold at the 2CFI value of the 500 nM
rhodamine sample. A two-component fit was used for samples
that exhibited improvements significantly larger than free rho-
damine, but otherwise a one-component fit was considered
adequate.
Table 1 lists the 2CFI values and the optimized fitting param-
eters of the most appropriate model for each sample. At a
sufficiently low concentration (100 nM), all four rhodamine-la-
beled Oxa1L-CTT derivatives were adequately fit by a single-
exponential model. The 2CFI values for the 500 nM samples
indicate that the fluorescence decay of rhodamine at positions
4, 67, and 94 is single-exponential, whereas rhodamine at posi-
tion 39 requires a biexponential fit. The longer time constant
for the Oxa39-Rh variant at 500 nMmatches the corresponding
time constant to 100 nM within experimental error. We attrib-
ute the shorter biexponential time constant to quenching upon
oligomer formation at the higher concentrations. These data
are consistent with the disulfide cross-linking and fluorescence
anisotropy results indicating that position 39 is in closest con-
tact when Oxa1L forms dimers in solution, as discussed above.
The FCS results demonstrate that all four Oxa1L-CTT vari-
ants bound ribosomes, but under the same conditions, TCSPC
shows that the fluorescence of rhodamine at position 4 was
unaffected, whereas rhodamine at positions 39, 67, and 94 was
significantly quenched. These data also confirm the steady-
state quenching presented in Fig. 6. They are consistent with
the model in which Oxa1L-CTT binds to ribosomes as a dimer
(or oligomer) because rhodamine at position 39 was quenched
at higher concentrations in the protein-only samples. Rhoda-
mine at positions 67 and 94 exhibited more quenching than
expected based on the protein-only data, which could be due to
a conformational change upon binding. Therefore, we con-
clude from the lifetime and steady-state fluorescence data that
Oxa1L-CTT binds to ribosomes as an oligomer and may
undergo a conformational change.
DISCUSSION
Oxa1L plays an important role in the insertion of proteins
into the inner membrane of mitochondria through an interac-
tion of the matrix-localized C-terminal tail with the large ribo-
somal subunit. Fig. 8 shows the schematic model for the orga-
nization of Oxa1L in the membrane and when it binds to
ribosomes. Our results indicate that human Oxa1L-CTT can
dimerize and that the formation of the dimer depends on con-
tacts around position 39 of the tail. Additional contacts are
likely to occur in the transmembrane helices (20). The interac-
tion near position 39 remains strong as the two Oxa1L-CTT
monomers bind to the ribosome. However, there are substan-
tial conformational changes in other regions of the C-terminal
tail when the protein binds to ribosomes, affecting especially
regions close to residues 67 and 94 (Fig. 8). These interactions
indicate a significant rearrangement of residues in the tail dur-
ing the formation of the functional Oxa1L-ribosome interac-
tion. The data also indicate that there is no detectable interac-
tion between the ribosome and regions of Oxa1L-CTT near
position 4. This residue is near the portion of theC-terminal tail
that emerges from the membrane, suggesting that contacts
between the ribosome andOxa1L aremediated by residues that
may be spatially separated from direct contact with the
membrane.
This work represents the first application of FCS and TCSPC
to the study of the binding of a ligand to mitochondrial ribo-
somes. FCS and TCSPC have previously been used widely for
monitoring biological events (21–25). For example, FCS was
used to study ligand binding to E. coli ribosomes (23) and to
monitor both in vivo and in vitro translation (24). In this work,
the use of static and dynamic fluorescence spectroscopy has
allowed us to monitor the segmental interactions within pro-
tein molecules and to map the interacting regions between
Oxa1L-CTT and mammalian mitochondrial ribosomes. We
have specifically introduced the use of tetramethylrhodamine
labeling and TCSPC as a means to assess the local polarity in
various regions of a protein by correlating the fluorescence life-
time enhancement with solvent-dependent lifetime data. This
approach could be applied to investigate the surface environ-
ment of other proteins. Finally, the combination of FCS and
fluorescence quenching was essential to confirm the associa-
tion of labeled proteins with mitochondrial ribosomes in solu-
tion and to provide spatial information about their interaction.
FCS is ideally suited to monitor the binding of individual pro-
teins to relatively massive ribosomes, and therefore, it could
become a valuable tool to study the interaction of other ligands
with ribosomes.
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